bdf 9148 has been researched along with sotalol in 1 studies
| Studies (bdf 9148) | Trials (bdf 9148) | Recent Studies (post-2010) (bdf 9148) | Studies (sotalol) | Trials (sotalol) | Recent Studies (post-2010) (sotalol) |
|---|---|---|---|---|---|
| 39 | 0 | 1 | 2,196 | 346 | 291 |
| Protein | Taxonomy | bdf 9148 (IC50) | sotalol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 3.8169 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 7.1087 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 7.2 | |
| Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | 5.0667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bristow, MR; Eki, Y; Focaccio, A; Krall, J; Movsesian, M; Peeters, G; Roden, R | 1 |
1 other study(ies) available for bdf 9148 and sotalol
| Article | Year |
|---|---|
Mechanism of action of OPC-8490 in human ventricular myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Action Potentials; Adult; Azetidines; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Enoximone; Heart; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Ion Channels; Middle Aged; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Piperazines; Pyridones; Quinolones; Sotalol; Ventricular Function; Veratridine | 1996 |